Human Genetics Programme, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.
Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, USA.
Sci Rep. 2024 Apr 15;14(1):8708. doi: 10.1038/s41598-024-58894-y.
Recent work has revealed an important role for rare, incompletely penetrant inherited coding variants in neurodevelopmental disorders (NDDs). Additionally, we have previously shown that common variants contribute to risk for rare NDDs. Here, we investigate whether common variants exert their effects by modifying gene expression, using multi-cis-expression quantitative trait loci (cis-eQTL) prediction models. We first performed a transcriptome-wide association study for NDDs using 6987 probands from the Deciphering Developmental Disorders (DDD) study and 9720 controls, and found one gene, RAB2A, that passed multiple testing correction (p = 6.7 × 10). We then investigated whether cis-eQTLs modify the penetrance of putatively damaging, rare coding variants inherited by NDD probands from their unaffected parents in a set of 1700 trios. We found no evidence that unaffected parents transmitting putatively damaging coding variants had higher genetically-predicted expression of the variant-harboring gene than their child. In probands carrying putatively damaging variants in constrained genes, the genetically-predicted expression of these genes in blood was lower than in controls (p = 2.7 × 10). However, results for proband-control comparisons were inconsistent across different sets of genes, variant filters and tissues. We find limited evidence that common cis-eQTLs modify penetrance of rare coding variants in a large cohort of NDD probands.
最近的研究揭示了罕见的、不完全外显遗传编码变异在神经发育障碍(NDD)中的重要作用。此外,我们之前已经表明,常见变异也会增加罕见 NDD 的风险。在这里,我们通过使用多顺式表达数量性状基因座(cis-eQTL)预测模型来研究常见变异是否通过改变基因表达来发挥作用。我们首先使用来自解码发育障碍(DDD)研究的 6987 名患者和 9720 名对照者进行了全转录组关联研究,发现了一个基因 RAB2A 通过了多次测试校正(p=6.7×10)。然后,我们调查了在 1700 个三核苷酸重复序列中,常见的 cis-eQTL 是否改变了由 NDD 患者从未受影响的父母那里继承的潜在有害的罕见编码变异的外显率。我们没有发现证据表明传递潜在有害编码变异的未受影响的父母比他们的孩子具有更高的基因预测表达。在携带受限制基因中潜在有害变异的患者中,这些基因在血液中的基因预测表达低于对照组(p=2.7×10)。然而,在不同的基因集、变异筛选和组织中,患者与对照组之间的比较结果不一致。我们发现有限的证据表明,在 NDD 患者的大队列中,常见的 cis-eQTL 可以改变罕见编码变异的外显率。